tirzepatide gout risk and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial Mounjaro and Gout: UK Guide
Description
GLP-1 pathway Tirzepatide activates GLP-1 (glucagon-like peptide-1) receptors at about one-fifth the potency of natural GLP-1
Clinical pharmacokinetics of semaglutide: a systematic review
They are injectable medications that have been approved to treat type 2 diabetes and, at higher doses, chronic weight control
Research also shows that tirzepatide tends to produce better blood sugar control than semaglutide
